AI assistant
Sending…
GlaxoSmithKline PLC — Director's Dealing 2017
May 22, 2017
5262_dirs_2017-05-22_167430ed-5683-4855-897e-7694fb252476.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 8831F
GlaxoSmithKline PLC
22 May 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
| 1. | Details of PDMR/person closely associated with them ('PCA') | ||||
| a) | Name | Mr R G Connor | |||
| b) | Position/status | President, Global Manufacturing & Supply | |||
| c) | Initial notification/ amendment |
Initial Notification | |||
| 2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | GlaxoSmithKline plc | |||
| b) | LEI | 5493000HZTVUYLO1D793 | |||
| 3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
| a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 |
|||
| b) | Nature of the transaction | The sale of 16,065 Ordinary Shares on 19 May 2017 at a price of £16.4227. | |||
| c) | Price(s) and volume(s) |
Price(s) | Volume(s) | ||
| £16.4227 | 16,065 | ||||
| d) | Aggregated information | n/a (single transaction) | |||
| Aggregated volume Price | |||||
| e) | Date of the transaction | 2017-05-19 | |||
| f) | Place of the transaction | London Stock Exchange (XLON) |
| 1. | Details of PDMR/person closely associated with them ('PCA') | ||||
| a) | Name | Mrs D Connor | |||
| b) | Position/status | PCA of Mr R G Connor (President, Global Manufacturing & Supply) | |||
| c) | Initial notification/ amendment |
Initial Notification | |||
| 2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
| a) | Name | GlaxoSmithKline plc | |||
| b) | LEI | 5493000HZTVUYLO1D793 | |||
| 3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
| a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 |
|||
| b) | Nature of the transaction | The sale of 7,435 Ordinary Shares on 19 May 2017 at a price of £16.4153. | |||
| c) | Price(s) and volume(s) |
Price(s) | Volume(s) | ||
| £16.4153 | 7,435 | ||||
| d) | Aggregated information | n/a (single transaction) | |||
| Aggregated volume Price | |||||
| e) | Date of the transaction | 2017-05-19 | |||
| f) | Place of the transaction | London Stock Exchange (XLON) |
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHELLFLDEFXBBK
More from GlaxoSmithKline PLC
Report Publication Announcement
2026
May 22
Regulatory Filings
2026
May 22
Director's Dealing
2026
May 20
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 20
Director's Dealing
2026
May 19
Regulatory Filings
2026
May 19
Transaction in Own Shares
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18